The advent of antibiotics in the early twentieth century catalyzed a medical revolution,
drastically reducing mortality due to bacterial infections. Along with numerous other …

Immune therapy to ease the burden of sepsis has thus far failed to consistently improve
patient outcomes. Advances in cancer immune therapy and awareness that prolonged …

Microphysiological systems, also known as organ‐on‐a‐chip platforms, show promise for
the development of new testing methods that can be more accurate than both conventional …

The ongoing coronavirus disease 2019 (COVID‐19) pandemic highlights the importance of
developing effective virus targeting strategies to treat and prevent viral infections. Since virus …

The current drug development practice lacks reliable and sensitive techniques to evaluate
the immunotoxicity of drug candidates, ie, their effect on the human immune system. This, in …

Sepsis is a rapidly progressing, life threatening immune response triggered by infection that
affects millions worldwide each year. Current clinical diagnosis relies on broad physiological …

Improved sample preparation has the potential to address unmet needs for fast turnaround
sepsis tests. In this work, we report elasto‐inertial based rapid bacteria separation from …

Because of its high incidence and clinical complexity, sepsis is a major challenge to
clinicians and researchers and a global burden to healthcare systems and society. Despite …

Engineered probiotics have the potential to diagnose and treat a variety of gastrointestinal
(GI) diseases. However, these exogenous bacterial agents have limited ability to effectively …

Blood infection can release toxic bacterial lipopolysaccharides (LPSs) into bloodstream,
trigger a series of inflammatory reactions, and eventually lead to multiple organ dysfunction …